Articles dans des revues avec comité de lecture (66)
  1. 60. Hallin, M., Denis, O., Deplano, A., De Ryck, R., Crèvecoeur, S., Rottiers, S., De Mendonça, R., & Struelens, M. (2008). Evolutionary relationships between sporadic and epidemic strains of healthcare-associated methicillin-resistant Staphylococcus aureus. Clinical microbiology and infection, 14(7), 659-669. doi:10.1111/j.1469-0691.2008.02015.x
  2. 61. Struelens, M., Denis, O., Rodriguez Villalobos, H., & Hallin, M. (2007). La résistance aux antibiotiques: origine, impact et perspectives de santé publique. Revue médicale de Bruxelles, 28(4), 381-384.
  3. 62. Hallin, M., Denis, O., Deplano, A., De Mendonça, R., De Ryck, R., Rottiers, S., & Struelens, M. (2007). Genetic relatedness between methicillin-susceptible and methicillin-resistant Staphylococcus aureus: Results of a national survey. Journal of antimicrobial chemotherapy, 59(3), 465-472. doi:10.1093/jac/dkl535
  4. 63. Hallin, M., Deplano, A., Denis, O., De Mendonça, R., De Ryck, R., & Struelens, M. (2007). Validation of pulsed-field gel electrophoresis and spa typing for long-term, nationwide epidemiological surveillance studies of Staphylococcus aureus infections. Journal of clinical microbiology, 45(1), 127-133. doi:10.1128/JCM.01866-06
  5. 64. Denis, O., Deplano, A., Nonhoff, C., Hallin, M., De Ryck, R., Vanhoof, R., De Mendonça, R., & Struelens, M. (2006). In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals. Antimicrobial agents and chemotherapy, 50(8), 2680-2685. doi:10.1128/AAC.00272-06
  6. 65. Denis, O., Deplano, A., De Beenhouwer, H., Hallin, M., Huysmans, G., Garrino, M. G., Glupczynski, Y., Malaviolle, X., Vergison, A., & Struelens, M. (2005). Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. Journal of antimicrobial chemotherapy, 56(6), 1103-1106. doi:10.1093/jac/dki379
  7. 66. Hallin, M., Maes, N., Byl, B., Jacobs, F., De Gheldre, Y., & Struelens, M. (2003). Clinical impact of a PCR assay for identification of Staphylococcus aureus and determination of methicillin resistance directly from blood cultures. Journal of clinical microbiology, 41(8), 3942-3944. doi:10.1128/JCM.41.8.3942-3944.2003
    8.   Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (1)
  8. 1. Vincart, B., Hallin, M., Struelens, M., & Denis, O. (2008). Authors' reply to 'Misidentification of Bordetella bronchiseptica as Bordetella pertussis using a newly described RT-PCR targeting the pertactin gene'. Journal of Medical Microbiology, 57(3), 399-400. doi:10.1099/jmm.0.47653-0
    9.   Participations à des congrès et colloques internationaux (3)
  9. 1. Yin, N., Van den Wijngaert, S., Mekkaoui, L., Michel, C., Zorzi, G., Van Cauteren, D., Hallin, M., Martiny, D., & Vandenberg, O. (2022). Leveraging of the semi-quantification of SARS-CoV-2 RT-PCR results to forecast epidemic trends. Abstract session presented at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)(32nd: 23-26 April 2022: Lisboa, Portugal)
  10. 2. Yin, N., Van Nuffelen, M., Bartiaux, M., Preseau, T., Roggen, I., Delaunoy, S., Mahadeb, B., Dahma, H., Busson, L., Vandenberg, O., & Hallin, M. (2021). Détection moléculaire rapide des virus respiratoires aux urgences : Impact clinique. Abstract session presented at RÉUNION INTERDISCIPLINAIRE DE CHIMIOTHÉRAPIE ANTI-INFECTIEUSE (RICAI)(41: 13-14 décembre 2021: Paris)
  11. 3. Goudji, C., Meghraoui, A., Yin, N., Barro, M., Echahidi, F., Miendje Deyi, Y. V., Michel, C., Hallin, M., Martiny, D., & Montesinos Hernandez, I. (2019). Interpretation of Legionella pneumophila urinary antigen tests (BinaxNOW™) by the Alere™ reader/ DIGIVAL™ in comparison to the human eye. Poster présenté à la conférence RBSLM Annual Meeting (2019: Brussels).
    12.   Participation aux jurys de thèse (2)
  12. 1. Frost, H. (2020). Characterisation of the Group A Streptococcus M and M-like proteins as potential vaccine antigens (Thèse doctorale non-publiée). Université libre de Bruxelles, Faculté de Médecine – Sciences biomédicales, Bruxelles.
    13. << Précédent 1 2 3 4 5 6 7 Suivant >>